An Overview of Current Glaucomatous Trabecular Meshwork Models.

3D culture Glaucoma model in vitro model outflow tissue engineering trabecular meshwork

Journal

Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312

Informations de publication

Date de publication:
04 Sep 2023
Historique:
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: aheadofprint

Résumé

To provide an overview of the existing alternative models for studying trabecular meshwork (TM). Literature review. The TM is a complex tissue that regulates aqueous humor outflow from the eye. Dysfunction of the TM is a major contributor to the pathogenesis of open-angle glaucoma, a leading cause of irreversible blindness worldwide. The TM is a porous structure composed of trabecular meshwork cells (TMC) within a multi-layered extracellular matrix (ECM). Although dysregulation of the outflow throughout the TM represents the first step in the disease process, the underlying mechanisms of TM degeneration associate cell loss and accumulation of ECM, but remain incompletely understood, and drugs targeting the TM are limited. Therefore, experimental models of glaucomatous trabeculopathy are necessary for preclinical screening, to advance research on this disease's pathophysiology, and to develop new therapeutic strategies targeting the TM. Traditional animal models have been used extensively, albeit with inherent limitations, including ethical concerns and limited translatability to humans. Consequently, there has been an increasing focus on developing alternative This review provides an overview of the existing alternative models for studying TM and their potential for advancing research on the pathophysiology of open-angle glaucoma and developing new therapeutic strategies.

Identifiants

pubmed: 37661784
doi: 10.1080/02713683.2023.2253378
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Auteurs

Juliette Buffault (J)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France.
Institut de la Vision, Sorbonne Université, INSERM, CNRS, IHU Foresight, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Versailles Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France.

Françoise Brignole-Baudouin (F)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, IHU Foresight, Paris, France.
Department of Biology, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France.

Antoine Labbé (A)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France.
Institut de la Vision, Sorbonne Université, INSERM, CNRS, IHU Foresight, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Versailles Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France.

Christophe Baudouin (C)

Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU Foresight, Paris, France.
Institut de la Vision, Sorbonne Université, INSERM, CNRS, IHU Foresight, Paris, France.

Classifications MeSH